GLYMAB

Welcome to the Brand page for “GLYMAB”, which is offered here for Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; compounds for the treatment of cancer;.

Its status is currently believed to be active. Its class is unavailable. “GLYMAB” is believed to be currently owned by “Scancell Limited”.

Owner:
SCANCELL LIMITED
Owner Details
Description:
Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; compounds for the treatment of cancer;
Categories: PHARMACEUTICAL